公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1986 | Characterization of rous sarcoma virus-related sequences in the Japanese quail | Chambers, J. A.; Cywinski, A.; PEI-JER CHEN ; Taylor, J. M. | Journal of Virology | 7 | 11 | |
2004 | Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: Molecular epidemiology and genome evolution | Shiou-Hwei Yeh ; HURNG-YI WANG ; Tsai C.-Y.; CHUAN-LIANG KAO ; Yang J.-Y.; Liu H.-W.; Su I.-J.; Tsai S.-F.; DING-SHINN CHEN ; PEI-JER CHEN ; Lee Y.-T.; Teng C.-M.; PAN-CHYR YANG ; HONG-NERNG HO ; MING-FU CHANG ; JIN-TOWN WANG ; SHAN-CHWEN CHANG ; Wang W.-K.; Hsiao C.-H.; PO-REN HSUEH | Proceedings of the National Academy of Sciences of the United States of America | 108 | 98 | |
1994 | Characterization of T cell clones specific to a determinant of hepatitis B virus core and e antigens in chronic type B hepatitis: Implication for a T cell mechanism of HBV immunopathogenesis | Tsai S.-L.; PEI-JER CHEN ; PEI-MING YANG ; Liao T.-H.; Sung J.-L.; Lai M.-Y.; Huang J.-H.; Chang T.-H.; DING-SHINN CHEN | Journal of Biomedical Science | 8 | 0 | |
1999 | Characterization of the phosphorylated forms and the phosphorylated residues of hepatitis delta virus delta antigens | Mu J.-J.; Wu H.-L.; BOR-LUEN CHIANG ; Chang R.-P.; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Virology | 34 | 32 | |
1988 | Characterization of the spectrum of postthymic T‐cell malignancies in Taiwan a clinicopathologic study of HTLV‐1‐positive and HTLV‐1‐negative cases | Su I.-J.; Wang C.-H.; ANN-LII CHENG ; YAO-CHANG CHEN ; Hsieh H.-C.; HWEI-FANG TIEN ; Huang S.-S.; CHUNG-YI HU ; PEI-JER CHEN ; Chen J.-Y.; Hsu H.-C.; Chuang S.-M.; MING-CHING SHEN ; Kadin M.E. | Cancer | 45 | ||
1989 | Characterization of the Transcripts of Hepatitis D and B Viruses in Infected Human Livers | PEI-JER CHEN ; PEI-MING YANG ; Chen C.-R.; DING-SHINN CHEN | Journal of Infectious Diseases | 5 | 4 | |
2004 | Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: Basis for the in vitro screening of anti-SARS drugs | Lin C.-W.; Tsai C.-H.; Tsai F.-J.; PEI-JER CHEN ; Lai C.-C.; Wan L.; Chiu H.-H.; Lin K.-H. | FEBS Letters | 37 | 36 | |
2014 | Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study | CHIUN HSU ; Tsou H.-H.; Lin S.-J.; Wang M.-C.; MING YAO ; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; HWEI-FANG TIEN ; Liu T.-W.; PEI-JER CHEN ; ANN-LII CHENG | Hepatology | 227 | 210 | |
1999 | Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization | Chen Y.-J.; JENG-YUH KO ; PEI-JER CHEN ; Shu C.-H.; Hsu M.-T.; Tsai S.-F.; Lin C.-H. | Genes Chromosomes and Cancer | 103 | ||
2001 | Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma | Shiou-Hwei Yeh ; PEI-JER CHEN ; Shau W.-Y.; Chen Y.-W.; PO-HUANG LEE ; Chen J.-T.; DING-SHINN CHEN | Gastroenterology | 99 | 93 | |
2002 | Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization | Chen Y.-J.; PEI-JER CHEN ; Lee M.-C.; Shiou-Hwei Yeh ; Hsu M.-T.; Lin C.-H. | Genes Chromosomes and Cancer | 33 | 31 | |
2000 | Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma | Chen Y.-J.; Shiou-Hwei Yeh ; Chen J.-T.; Wu C.-C.; Hsu M.-T.; Tsai S.-F.; PEI-JER CHEN ; Lin C.-H. | Gastroenterology | 213 | 196 | |
2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 29 | 26 | |
2016 | Chronic Hepatitis B virus infection | Yuen M.-F.; Ahn S.H.; Chen D.-S.; PEI-JER CHEN ; Dusheiko G.M.; Hou J.-L.; Maddrey W.C.; Mizokami M.; Seto W.-K.; Zoulim F.; Lai C.-L. | Journal of Clinical Gastroenterology | 36 | 41 | |
2010 | Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions | Ahn S.H.; Chan H.L.Y.; PEI-JER CHEN ; Cheng J.; Goenka M.K.; Hou J.; Lim S.G.; Omata M.; Piratvisuth T.; Xie Q.; Yim H.J.; Yuen M.-F. | Hepatology International | 38 | 41 | |
1996 | Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay: A clinicopathologic study and demonstration of the usefulness of a third-generation assay | JIA-HORNG KAO ; Lai M.-Y.; Hwang Y.-T.; PEI-MING YANG ; PEI-JER CHEN ; JIN-CHUAN SHEU ; Wang T.-H.; Hsu H.-C.; DING-SHINN CHEN | Digestive Diseases and Sciences | 48 | 44 | |
2017 | Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan | HONG-YUAN HSU ; MEI-HWEI CHANG ; YEN-HSUAN NI ; Chiang C.-L.; JIA-FENG WU ; HUEY-LING CHEN ; PEI-JER CHEN ; Chen D.-S. | Journal of Viral Hepatitis | 17 | 13 | |
2004 | Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus | PO-REN HSUEH ; LI-MIN HUANG ; PEI-JER CHEN ; CHUAN-LIANG KAO ; PAN-CHYR YANG | Clinical Microbiology and Infection | 197 | 181 | |
2010 | CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells | Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; TSUNG-HAO LIU ; Hou D.-R.; PEI-JER CHEN ; ANN-LII CHENG | Oncogene | 148 | 139 | |
2014 | Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870 | Cheng H.-Y.; Kang P.-J.; YA-HUI CHUANG ; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN ; Lee S.-D.; MING-WHEI YU | PLoS ONE | 65 | 25 |